📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants. (2020)

First Author: Pestinger V

Attributed to: Integrating innovative technologies for genotyping and phenotyping in stratified medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40291-020-00479-2

PubMed Identifier: 32572786

Publication URI: http://europepmc.org/abstract/MED/32572786

Type: Journal Article/Review

Volume: 24

Parent Publication: Molecular diagnosis & therapy

Issue: 4

ISSN: 1177-1062